Funding Rounds
Eligo Bioscience

Eligo Bioscience Series B (2023, $30M)

Eligo Bioscience

Gene-editing platform.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $30.03M

Raised Date: 2023-05-01

Investors